PubMed for id: 4154

Year	Number of Results
1996	1
1997	1
2000	1
2001	2
2002	2
2004	3
2005	3
2006	4
2007	2
2008	3
2009	4
2010	1
2011	12
2012	13
2013	6
2014	6
2015	9
2016	4
2017	9
2018	13
2019	7
2020	9
2021	9
2022	13
2023	5
2024	0

1

MBNL-dependent impaired development within the neuromuscular system in myotonic dystrophy type 1.

Tahraoui-Bories J, Mérien A, González-Barriga A, Lainé J, Leteur C, Polvèche H, Carteron A, De Lamotte JD, Nicoleau C, Polentes J, Jarrige M, Gomes-Pereira M, Ventre E, Poydenot P, Furling D, Schaeffer L, Legay C, Martinat C. Tahraoui-Bories J, et al. Neuropathol Appl Neurobiol. 2023 Feb;49(1):e12876. doi: 10.1111/nan.12876. Neuropathol Appl Neurobiol. 2023. PMID: 36575942 Free PMC article.

2

Cognate RNA-Binding Modes by the Alternative-Splicing Regulator MBNL1 Inferred from Molecular Dynamics.

González ÀL, Fernández-Remacha D, Borrell JI, Teixidó J, Estrada-Tejedor R. González ÀL, et al. Int J Mol Sci. 2022 Dec 18;23(24):16147. doi: 10.3390/ijms232416147. Int J Mol Sci. 2022. PMID: 36555788 Free PMC article.

3

MBNL1 Suppressed Cancer Metastatic of Skin Squamous Cell Carcinoma Via by TIAL1/MYOD1/Caspase-9/3 Signaling Pathways.

Chen J, Wang J, Qian J, Bao M, Zhang X, Huang Z. Chen J, et al. Technol Cancer Res Treat. 2021 Jan-Dec;20:1533033820960755. doi: 10.1177/1533033820960755. Technol Cancer Res Treat. 2021. PMID: 33896245 Free PMC article.

4

Altered Expression of MBNL Family of Alternative Splicing Factors in Colorectal Cancer.

Navvabi N, Kolikova P, Hosek P, Zitricky F, Navvabi A, Vycital O, Bruha J, Palek R, Rosendorf J, Liska V, Pitule P. Navvabi N, et al. Cancer Genomics Proteomics. 2021 May-Jun;18(3):295-306. doi: 10.21873/cgp.20260. Cancer Genomics Proteomics. 2021. PMID: 33893082 Free PMC article.

5

[Effect of long non-coding RNA MBNL1-AS1 expression on prognosis of acute myeloid leukemia patients].

Xie W, Qian TT, Pang Y, Ye X, Huang WH, Zhu P, Fu L. Xie W, et al. Zhonghua Yi Xue Za Zhi. 2021 Apr 6;101(13):934-938. doi: 10.3760/cma.j.cn112137-20200930-02754. Zhonghua Yi Xue Za Zhi. 2021. PMID: 33789374 Chinese.

6

The Alternative Splicing Factor, MBNL1, Inhibits Glioblastoma Tumor Initiation and Progression by Reducing Hypoxia-Induced Stemness.

Voss DM, Sloan A, Spina R, Ames HM, Bar EE. Voss DM, et al. Cancer Res. 2020 Nov 1;80(21):4681-4692. doi: 10.1158/0008-5472.CAN-20-1233. Epub 2020 Sep 14. Cancer Res. 2020. PMID: 32928918 Free PMC article.

7

MBNL1 reverses the proliferation defect of skeletal muscle satellite cells in myotonic dystrophy type 1 by inhibiting autophagy via the mTOR pathway.

Song KY, Guo XM, Wang HQ, Zhang L, Huang SY, Huo YC, Zhang G, Feng JZ, Zhang RR, Ma Y, Hu QZ, Qin XY. Song KY, et al. Cell Death Dis. 2020 Jul 18;11(7):545. doi: 10.1038/s41419-020-02756-8. Cell Death Dis. 2020. PMID: 32683410 Free PMC article.

8

MBNL splicing activity depends on RNA binding site structural context.

Taylor K, Sznajder LJ, Cywoniuk P, Thomas JD, Swanson MS, Sobczak K. Taylor K, et al. Nucleic Acids Res. 2018 Sep 28;46(17):9119-9133. doi: 10.1093/nar/gky565. Nucleic Acids Res. 2018. PMID: 29955876 Free PMC article.

9

MBNL expression in autoregulatory feedback loops.

Konieczny P, Stepniak-Konieczna E, Sobczak K. Konieczny P, et al. RNA Biol. 2018 Jan 2;15(1):1-8. doi: 10.1080/15476286.2017.1384119. Epub 2017 Nov 13. RNA Biol. 2018. PMID: 28949831 Free PMC article.

10

Muscleblind-like 1 suppresses breast cancer metastatic colonization and stabilizes metastasis suppressor transcripts.

Fish L, Pencheva N, Goodarzi H, Tran H, Yoshida M, Tavazoie SF. Fish L, et al. Genes Dev. 2016 Feb 15;30(4):386-98. doi: 10.1101/gad.270645.115. Genes Dev. 2016. PMID: 26883358 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

132 results

Results by year